Category: Judicial

In Unanimous Decision, Fed Appeals Court Reverses Lower Court Ruling and Allows 340B Antitrust Lawsuit Against Insulin Drugmakers to Advance

August 7, 2025 Shannon Young, Associate Editor/Senior Writer Views

The U.S. 2nd Circuit Court of Appeals' 3-0 decision reversed a lower court’s 2024 ruling that had denied health centers' antitrust claims against four drug manufacturers that have placed contract pharmacy restrictions.

A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Touts 340B Rebate Pilot Proposal to Appeals Court, Hospitals File Amicus Brief Urging Court to Reject Rebates

August 7, 2025 Shannon Young, Associate Editor/Senior Writer Views

HHS highlighted its proposed 340B rebate pilot in an Aug. 1 brief filed with the U.S. Court of Appeals for the District of Columbia Circuit.

The U.S. Department of Health and Human Services (HHS) touted the agency’s recently announced plan to pilot a 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Judge Rejects HHS’ Partial Motion to Dismiss in Drugmakers’ Lawsuit Challenging STD Site Recertifications

August 7, 2025 Shannon Young, Associate Editor/Senior Writer Views

The U.S. District Court for the District of Columbia, denied HHS’ partial motion to dismiss drugmakers’ claims in a lawsuit alleging that the federal government allowed certain STD clinics to unlawfully participate in the 340B program.

A Washington D.C. federal court this week rejected the Department of Health and Human Services’ (HHS) request to partially dismiss [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie, Novartis Sue Oregon Over New 340B Contract Pharmacy Access Law

August 5, 2025 William Newton, Associate Editor/Senior Writer Views

Drugmakers AbbVie and Novartis recently filed separate federal lawsuits challenging Oregon's new 340B contract pharmacy access law.

AbbVie and Novartis recently became the first drugmakers to file lawsuits challenging Oregon’s new law prohibiting 340B contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Hearing in Utah; Updates in Colorado, Nebraska, Oklahoma

August 5, 2025 William Newton, Associate Editor/Senior Writer Views

Key hearings and briefs occurred in ongoing litigation on 340B contract pharmacy access laws in Utah, Colorado, Nebraska and Oklahoma.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Proposes 340B Rebate Model Pilot for Narrow Set of Drugs Under Strict Conditions

July 31, 2025 William Newton, Associate Editor/Senior Writer Views

The Health Resources and Services Administration published its highly-anticipated proposed 340B rebate guidance this morning, proposing a narrowly-scoped pilot program.

The Health Resources and Services Administration unveiled its highly anticipated proposed 340B rebate guidance on the morning of July 31.

The Health Resources and Services Administration (HRSA) today unveiled its highly anticipated 340B rebate guidance, proposing a pilot program that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Who Are the Federal Judges Deciding the High-Stakes Drugmaker 340B Rebate Appeals?

July 31, 2025 William Newton, Associate Editor/Senior Writer Views

Circuit Judges Neomi Rao, Patricia Millett and Cornelia Pillard are scheduled to hear oral arguments in Washington, D.C. this September on a five drug companies' 340B rebate appeal.

Three federal appeals judges—who have all ruled on 340B matters in the past—will hear oral arguments in September in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Patient Groups Back Drugmakers in 340B Rebate Appeal, Without Disclosing Drug Industry Funding or Missed Compliance Deadline

July 29, 2025 William Newton, Associate Editor/Senior Writer Views

Three patient groups recently told a federal appeals court that a 340B rebate model “is essential to the effort to bring transparency to 340B.” One of those groups did not disclose its financial ties to drugmakers, and another is out of compliance with state public reporting laws.

Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

July 22, 2025 William Newton, Associate Editor/Senior Writer Views

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.

A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Judge Dismisses AbbVie’s Challenge to Missouri’s 340B Contract Pharmacy Access Law for Lack of Standing

July 15, 2025 William Newton, Associate Editor/Senior Writer Views

A federal district judge recently dismissed AbbVie's complaint against Missouri's 340B contract pharmacy access law for a lack of standing.

A federal district judge has dismissed AbbVie’s lawsuit challenging Missouri’s 340B contract pharmacy access law, marking another legal setback for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live